Artelo biosciences stock.
The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. Price Target Upside/Downside. According to ...
Artelo Biosciences Inc. Artelo Biosciences Inc. (NASDAQ: ARTL) stock closed at 1.28 per share at the end of the most recent trading day (a 5.25% change compared to the prior day closing price) with a volume of 5.86K shares and market capitalization of 4.08M. Is a component of indices and it is traded on NASDAQ exchange.SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced new research published in …Dec 1, 2023 · When is Artelo Biosciences's earnings date? Artelo Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off last year's report dates. Learn more on ARTL's earnings history. Stock analysis for Artelo Biosciences Inc (ARTL:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Artelo Biosciences currently has issued a total of 2,860,000 shares. Some of Artelo Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market.
Based on 3 Wall Street analysts offering 12 month price targets for Artelo Biosciences in the last 3 months. The average price target is $16.67 with a high ...Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Artelo Biosciences Inc have a median target of 5.00, with a high estimate of 40.00 and a low estimate of 5.00. The median ...Artelo Biosciences General Information. Description. Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication …
About Artelo Biosciences Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system.
Artelo Biosciences Inc stock performance at a glance. Check Artelo Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Artelo Biosciences Inc stock performance at a glance. Check Artelo Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ARTL Stock Performance. USD USD; Previous close: 1.38: 1.38: Day range: 1.36 - 1.45991.36 - 1.4599Year range: 1 - 31 - 3Artelo Biosciences Inc stock performance at a glance. Check Artelo Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its …Artelo Biosciences Inc stock performance at a glance. Check Artelo Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Artelo Biosciences Inc stock performance at a glance. Check Artelo Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.
Complete Artelo Biosciences Inc. Wt stock information by Barron's. View real-time ARTLW stock price and news, along with industry-best analysis.
Artelo’s Board of Directors approved a 15-for-1 reverse stock split of the Company’s common stock. The Company’s common shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing at the market open, August 10, 2022.
Nov 29, 2023 · The Artelo Biosciences, Inc. stock price gained 11.60% on the last trading day (Wednesday, 29th Nov 2023), rising from $1.23 to $1.37. During the last trading day the stock fluctuated 12.90% from a day low at $1.24 to a day high of $1.40. The price has fallen in 6 of the last 10 days but is still up by 4.79% over the past 2 weeks. Company Overview Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of …Dec 2, 2023 · Artelo Biosciences Stock Forecast and Price Target. The average price target of $5.00 for Artelo Biosciences's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 247.22% from the last closing price in December, 2023 if reached by the end of the year. Artelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, Ireland finance.yahoo.com - June 24 at 8:51 AM: Artelo Biosciences (NASDAQ:ARTLW), Short Interest Report benzinga.com - June 13 at 10:55 PM: Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th …Artelo Biosciences Stock Forecast and Price Target The average price target of $5.00 for Artelo Biosciences's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 247.22% from the last closing price in December, 2023 if reached by the end of the year.
artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. our programs have the potential to dramatically improve patient care in major markets. with our ...Nov 10, 2023 · Negative. Nikkei 225. 32,568.11. -0.24%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Artelo Biosciences Inc (ARTL.OQ) real-time stock quotes, news, price and financial ... Nov 29, 2023 · The Artelo Biosciences, Inc. stock price gained 11.60% on the last trading day (Wednesday, 29th Nov 2023), rising from $1.23 to $1.37. During the last trading day the stock fluctuated 12.90% from a day low at $1.24 to a day high of $1.40. The price has fallen in 6 of the last 10 days but is still up by 4.79% over the past 2 weeks. Overview News Artelo Biosciences Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-3.32 Market Cap $4.58 M Shares …Announces Plans to File IND Application in Neuropathic PainSOLANA BEACH, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company ...r/ARTLStock: All about Artelo Biosciences Stock - #ARTLARTL Stock 12 Months Forecast. $16.67. (1244.35% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Artelo Biosciences in the last 3 months. The average price target is $16.67 with a high forecast of $40.00 and a low forecast of $5.00. The average price target represents a 1244.35% change from the last price of $1.24.
Artelo Biosciences. $17.5 Million in Cash and Marketable Securities as of December 31, 2022; Expected to Support Operations Into Second Half of 2024. SOLANA BEACH, Calif., March 31, 2023 (GLOBE ...
See the latest Artelo Biosciences Inc stock price (ARTL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.7 сент. 2023 г. ... Artelo Biosciences Inc (ARTL) is higher by Thursday morning, with the stock gaining 23.40% in pre-market trading to 2.9.Artelo Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023. Aug. 10. CI. Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on …SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced new research published in …Nov 10, 2023 · Negative. Nikkei 225. 32,568.11. -0.24%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Artelo Biosciences Inc (ARTL.OQ) real-time stock quotes, news, price and financial ... artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. our programs have the potential to dramatically improve patient care in major markets. with our ...Nov 14, 2023 · The latest price target for Artelo Biosciences ( NASDAQ: ARTL) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a price target for 5.00 expecting ARTL to ... As of November 16, 2023, Artelo Biosciences Inc had a $3.7 million market capitalization, putting it in the 8th percentile of companies in the Biotechnology & Medical Research industry. Artelo Biosciences Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months.Real-Time News, Market Data, and Stock Quotes for Life Science Stocks @ healthstockshub.com Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany - …
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system (ECS), a family of receptors and neurotransmitters that form a biochemical communication network throughout the body.
Dec 1, 2023 · When is Artelo Biosciences's earnings date? Artelo Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off last year's report dates. Learn more on ARTL's earnings history.
Nov 2, 2023 · Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023. Oct 04, 2023 8:30am EDT. 41.70%. Get the latest Artelo Biosciences Inc (ARTL) real-time quote, historical performance, charts, and other financial information to help you make more informed …Artelo Biosciences Inc stock performance at a glance. Check Artelo Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Artelo Biosciences (Nasdaq:ARTL) - Stock Price, News & Analysis - Simply Wall St Stocks / Pharmaceuticals & Biotech Artelo Biosciences …According to the issued ratings of 2 analysts in the last year, the consensus rating for Artelo Biosciences stock is Buy based on the current 2 buy ratings for ARTL. The average twelve-month price prediction for Artelo Biosciences is $32.50 with a high price target of $60.00 and a low price target of $5.00. Learn more on ARTL's analyst rating ...Find the latest Artelo Biosciences, Inc. (ARTL) stock quote, history, news and other vital information to help you with your stock trading and investing.View Artelo Biosciences, Inc ARTL investment & stock information. Get the latest Artelo Biosciences, Inc ARTL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Artelo Biosciences Inc is higher by Thursday morning, with the stock gaining 23.40% in pre-market trading to 2.9.ARTL's short-term technical score of 19 indicates that the stock has traded less bullishly over …
Dec 1, 2023. Investor Presentation - December 2023 . rss_feed RSSNov 29, 2023 · 2 Wall Street analysts have issued 12-month price targets for Artelo Biosciences' shares. Their ARTL share price targets range from $5.00 to $60.00. On average, they expect the company's share price to reach $32.50 in the next year. This suggests a possible upside of 2,267.6% from the stock's current price. View analysts price targets for ARTL ... Nov 30, 2023 · Artelo Biosciences, Inc. Stock News . NASDAQ Stock Exchange > Healthcare > Biotechnology Open Broker Account $1.38 +0.0073 (+0.532%) At Close: Nov 30, 2023 About the Artelo Biosciences, Inc. stock forecast. As of 2023 November 14, Tuesday current price of ARTLW stock is 0.02060$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Artelo Biosciences Inc - Warrants (18/06/2024) stock price has been showing a declining tendency so we believe …Instagram:https://instagram. dexcom inc. stockshopify price increasepp etf holdingsday trading spy options Artelo Biosciences Inc (ARTL) stock has gained 4.9% while the S&P 500 has fallen -0.12% as of 10:41 AM on Thursday, Nov 30. ARTL has gained $0.07 from the previous closing price of $1.37 on volume of 4,369 shares. Over the past year the S&P 500 is higher by 14.84% while ARTL has fallen -41.46%. ARTL lost -$3.33 per share in the …Artelo Biosciences, Inc. (ARTLW) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 0.0321 0.0000 (0.00%) At close: 09:47AM EST 1d 5d 1m 6m YTD 1y 5y rolls royce price stockiwm options Artelo Biosciences missed estimated earnings by 27.69%, reporting an EPS of $-0.83 versus an estimate of $-0.65. Revenue was down $0 from the same period last year. Past Earnings Performance agg price SOLANA BEACH, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop ...Home - Artelo Biosciences. About. Pipeline. Science. Investors. Media. Modifying lipid-signaling pathways to improve treatments for people living with cancer.